The real cost of MRSA

Antibiotic Policies: Theory and Practice

Volumn , Issue , 2005, Pages 281-309

  Dancer, Stephanie J ^a  

^a Scottish Centre for Infection and Environmental Health   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84901186429     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-22852-7_16     Document Type: Chapter

References (173)

1. Abramson, M. A. and Sexton, D. J., 1999, Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteraemia: At what costs? Infect. Control Hosp. Epidemiol., 20, 408-411.
2. Afif, W., Huor, P., Brassard P., and Loo, V G., 2002, Compliance with methicillin-resistant Staphylococcus aureus precautions in a teaching hospital. Am. J. Infect. Control, 30, 430-433.
3. Anonymous, 1985, In search of efficiency. Health Soc. Serv. J., 95, 1-8.
4. Arnold, M. S., Dempsey, J. M., Fishman, M., McAuley, P. J., Tibert, C, and Vallande, N. C, 2002, The best hospital practices form controlling methicillin-resistant Staphylococcus aureus: On the cutting edge. Infect. Control Hosp. Epidemiol., 23, 69-76.
5. Aucken, H. M., Ganner, M., Murchan, S., Cookson, B. D., and Johnson, A. P., 2002, A new UK strain of epidemic methicillin-resistant Staphyloccocus aureus (EMRSA-17) resistant to multiple antibiotics. J. Antimicrob. Chemother, 50, 171-175.
6. Ayliffe, G A. J., 1997, The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis., 24(Suppl.), 74-79.
7. Ayliffe, G A. J. et al., 1998, Report of combined Working Party of the British Society for Antimicrobial Chemotherapy, The Hospital Infection Society and the Infection Control Nurses Association. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. J. Hosp. Infect., 39, 253-290.
8. Bagshawe, K. D., Blowers, R, and Lidwell, O. M., 1978, Isolating patients in hospital to control infection. Part 1-Sources and routes of infection. BMJ, 2, 609-613.
9. Barrett, S. P., Mummery, R. V, and Chattopadhyay, B., 1998, Trying to control MRSA causes more problems than it solves. J. Hosp. Infect., 39, 85-93.
10. BBC Scotland, 2003, Call to close city hospital wards. Accessed at http://news.bbc.co.uk/l/hi/scotland/2937797.stm
11. Bloom, B. S., Fendrick, A. M., Chernew, M. E., and Patel, P., 1996, Clinical and economic effects of mupirocin calcium on prevention of Staphylococcus aureus infection in haemodialysis patients: A decision analysis. Am. J. Kidney Dis., 27, 687-694.
12. Blot, S. I., Vandewoude, K. H., Hoste, E. A., and Colardyn, F. A., 2002, Outcome and attributable mortality in critically ill patients with bacteraemia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch. Intern. Med., 162, 2229-2235.
13. Boyce, J. M., 1991, Should we vigorously try to contain and control methicillin-resistant Staphylococcus aureus? Infect. Control Hosp. Epidemiol., 12, 46-54.
14. Boyce, J. M., Potter-Bynoe, G., Chenevert, C, and King, T., 1997, Environmental contamination due to methicillin-resistant Staphylococcus aureus: Possible infection control implications. Infect. Control Hosp. Epidemiol., 18, 622-627.
15. Boyce, J. M., 1998, Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing? JAMA, 279, 623-624.
16. Brachman, P. S. and Haley, R. W., 1981, Nosocomial infection control: Role of the hospital administrator. Rev. Infect. Dis., 3, 783-784.
17. Bradley, J. M., Noone, P., Townsend, D. E., and Grubb, W. B., 1985, Methicillin-resistant Staphylococcus aureus in a London hospital, Lancet, 1, 1493-1495
18. Brooklyn Antibiotic Resistance Task Force, 2002, The cost of antibiotic resistance: Effect of resistance among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter bau-mannii, and Pseudomonas aeruginosa on length of hospital stay. Infect. Control Hosp. Epidemiol., 23, 106-108.
19. Capitano, B., Leshem, O. A., Nightingale, C. H., and Nicolau, D. P., 2003, Cost effect of managing methicillin-resistant Staphylococcus aureus in a long-term care facility. J. Am. Ger Soc, 51, 10-16.
20. Casewell, M. W., 1995, New threats to the control of methicillin- resistant Staphylococcus aureus. J. Hosp. Infect., 30(suppl), 465-471.
21. Chaix, C, Durand-Zaleski, I., Alberti, C, and Brun-Buisson, C, 1999, Control of endemic methicillin-resistant Staphylococcus aureus. A cost-benefit analysis in an intensive care unit. JAMA, 282, 1745-1751.
22. Coast, J., Smith, R. D., and Millar, M. R, 1996, Superbugs: Should antimicrobial resistance be included as a cost in economic evaluation? Health Econ., 5, 217-226.
23. Coast, J., Smith, R. D., Karcher, A. M., Wilton, P., and Millar, M., 2002, Superbugs II: How should economic evaluation be conducted for interventions, which aim to contain antimicrobial resistance? Health Econ., 11, 637-647.
24. Coello, R, Glenister, H., Fereres, J., Bartlett, C, Leigh, D., Sedgwick, J. et al., 1993, The cost of infection in surgical patients: A case-control study. J. Hosp. Infect., 25, 239-250.
25. Coello, R., Jimenez, J., Garcia, M., Arroyo, P., Minguez, D., Fernandez, C. et al., 1994, Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J. Clin. Microbiol. Infect. Dis., 13, 74-81.
26. Cohen, S. H., Morita, M. M., and Bradford, M., 1991, A seven-year experience with methicillin-resistant Staphylococcus aureus. Am. J. Med., 91, 233S-237S.
27. Cox, R. A., Conquest, C, Mallaghan, C, and Marples, R R., 1995, A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16). J. Hosp. Infect., 32, 73-78.
28. Dacre, J., Emmerson, A. M., and Jenner, E. A., 1986, Gentamicin- methicillin-resistant Staphylococcus aureus: Epidemiology and containment of an outbreak. J. Hosp. Infect., 7, 130-136.
29. Dancer, S. J., 1997, MRSA in the community: Who is responsible? SCIEH Weekly Report, 31(97/01), 2-4.
30. Dancer, S. J., 1999a, Mopping up hospital infection. J. Hosp. Infect., 43, 85-100.
31. Dancer, S. J., 1999b, Swinging back the MRSA pendulum? J. Hosp. Infect., 42, 69-71.
32. Dancer, S. J., 2001, The problem with cephalosporins. J. Antimicrob. Chemother, 48, 463-478.
33. Dancer, S. J., 2002, Hospital-acquired infection: Is cleaning the answer? CPD Infect., 3, 40-46.
34. Dancer, S. J., 2003, Glycopeptide resistance in Staphylococcus aureus. J. Antimicrob. Chemother, 51, 1309-1311.
35. Davey, P. G. and Nathwani, D, 1998, What is the value of preventing post-operative infections? New Horizon, 6(suppl. 2), S64-S71.
36. Diekema, D. J., Pfaller, M. A., Jones, R N, Doern, G V, Kugler, K. C., Beach, M. L. et al., 2000, Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group. Int. J. Antimicrob. Agents, 13, 257-271.
37. Diekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R N. et al., 2001, Survey of infections due to staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Programme, 1997-1999. SENTRY Participants Group. Clin. Infect. Dis., 32(suppl. 2), S114-S32.
38. Drew, R. H., Perfect, J. R, Srinath, L., Kurkimilis, E., Dowzicky, M., and Talbot, G H., 2000, Treatment of methicillin-resistant Staphyloccocus aureus infections with quin-upristin-dalfopristin in patients intolerant of or failing prior therapy. J. Antimicrob Chemother., 46, 775-784.
39. Drummond, M., Stoddart, G, and Torrance, G, 1989, Methods for Economic Evaluation of Health Care Programmes. Oxford University Press, Oxford, England, pp. 18-83.
40. Duckworth, G J., Lothian, J. L., and Williams, J. D, 1988, Methicillin-resistant Staphylococcus aureus: Report of an outbreak in a London teaching hospital. J. Hosp. Infect., 11, 1-15.
41. Duffy, K. R, 1985, Cost-effective applications of the Centres for Disease Control guidelines for prevention of nosocomial infections. Am. J. Infect. Control, 13, 216-217.
42. Dufour, P., Gillet, Y, Bes, M., Lina, G, Vandenesch, F., Floret, D, Etienne, J., and Richet, H., 2002, Community-acquired methicillin-resistant Staphylococcus aureus infections in France: Emergence of a single clone that produces Panton-Valentine leukocidin. Clin. Infect. Dis., 35, 819-824.
43. EARSS Annual Report, 2002, European Antimicrobial Resistance Surveillance System. Accessed at http://www.earss.rivm.nl.
44. Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R N, and Wenzel, R P., 1999, Nosocomial bloodstream infections in United States hospitals-a three-year analysis. Clin. Infect. Dis., 29, 239-244.
45. Emmerson, A. M., Enstone, J. E., Griffin, M., Kelsey, M. C, and Smyth, E. T. M., 1996, Second national prevalence survey of infections in hospitals-overview of the results. J. Hosp. Infect., 32, 175-190.
46. Engemann, J. J., Carmeli, Y, Cosgrove, S. E., Fowler, V. G, Bronstein, M. Z., Trivette, S. L. et al., 2003, Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin. Infect. Dis., 36, 592-598.
47. Farr, B. M. and Jarvis, W. R., 2002, Would active surveillance cultures help control healthcare-related methicillin-resistant Staphylococcus aureus infections? Infect. Control Hosp. Epidemiol., 23, 65-68.
48. Farr, B. M., Salgado, C. D., Karchmer, T. B., and Sherertz, R. J., 2001, Can antibiotic-resistant nosocomial infections be controlled? Lancet Infect. Dis., 1, 38-45.
49. Fitzpatrick, F, Murphy, O. M., Brady, A., Prout, S., and Fenelon, L. E., 2000, A purpose built MRSA cohort unit. J. Hosp. Infect., 46, 271-279.
50. Fraise, A. P., Mitchell, K., O'Brien, S. J., Oldfield, K., and Wise, R., 1997, Methicillin-resistant Staphylococcus aureus (MRSA) in nursing homes in a major UK city: An anonymised point prevalence survey. Epidemiol. Infect., 118, 1-5.
51. Frank, M. O., Batteiger, B. E., Sorensen, S. J., Hartstein, A. I., Carr, J. A., McComb, J. S. et al., 1997, Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program. Clin. Perform. Qual. Health Care, 5, 180-188.
52. Fry, D. E., 2002, The economic costs of surgical site infection. Surg. Infect. (Larchmt), 1, S37-S43.
53. Geissler, A., Gerbeaux, P., Granier, I., Blanc, P., Facon, K., and Durand-Gassell, 2003, Rational use of antibiotics in the intensive care unit: Impact of microbial resistance and costs. Intensive Care Med., 29, 49-54.
54. Geldner, G., Ruoff, M., Hoggmann, H. J., Kiefer, P., Georgieff, M., and Wiedeck, H., 1999, Cost analysis concerning MRSA infection in ICU. Anaesthesiol. Intensivmed. Notfallmed. Schmerzther, 34, 409-413.
55. Girou, E., Azar, J., Wolkenstein, P., Cizeau, F, Brun-Buisson, C, and Roujeau, J-C, 2000, Comparison of systematic versus selective screening for methicillin-resistant Staphylococcus aureus carriage in a high-risk dermatology ward. Infect. Control Hosp. Epidemiol., 21, 583-587.
56. Girou, E., Pujade, G, Legrand, P, Cizeau, F, and Brun-Buisson, C, 1998, Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin. Infect. Dis., 27, 543-550.
57. Gopal Rao, G, Jeanes, A., Osman, M., Aylott, C, and Green, J., 2002, Marketing hand hygiene in hospitals-a case study. J. Hosp. Infect., 50, 42-47.
58. Grundmann, H., Hori, S., Winter, B., Tami, A., and Austin, D. J., 2002, Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: Fitting to the data. J. Infect. Dis., 185, 481-488.
59. Gruson, D., Hilbert, G, Vargas, F, Valentino, R., Bebear, C, Allery, A. et al., 2000, Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. Am. J. Respir Crit. Care Med., 162, 837-843.
60. Haley, R. W, 1991, Measuring the costs of nosocomial infections: Methods for estimating economic burden on the hospital. Am. J. Med., 91, 32S-38S.
61. Haley, R. W, Culver, D. H., White, J. W, Morgan, W M., Emori, T. G, Munn, V P. et al., 1985, The efficacy of infection surveillance and control programme in preventing nosocomial infections in US hospitals. Am. J. Epidemiol., 121, 182-205.
62. Haley, R. W, Schaberg, D. R., Crossley, K. B., Von Allmen, S. D., and McGowan, J., Jr., 1981, Extra charges and prolongation of stay attributable to nosocomial infections: A prospective inter-hospital comparison. Am. J. Med., 70, 51-58.
63. Harbarth, S., Martin, Y., Rohner, P., Henry, N., Auckenthaler, R, and Pittet, D., 2000, Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J. Hosp. Infect., 46, 43-49.
64. Herold, B. C, Immergluck, L. C, Maranan, M. C, Lauderdale, D. S., Gaskin, R. E., Boyle-Vavra, S. et al. 1998, Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA, 279, 593-598.
65. Herwaldt, L., 1999, Control of methicillin-resistant Staphylococcus aureus in the hospital setting. Am. J. Med., 106, 11S-18S.
66. Hill, D. A., Herford, T., and Parratt, D., 1998, Antibiotic usage and methicillin-resistant Staphylococcus aureus: An analysis of causality. J. Antimicrob. Chemother, 42, 676-677'.
67. Hiramatsu, K., 2001, Vancomycin-resistant Staphylococcus aureus: A new model of antibiotic resistance. Lancet Infect. Dis., 1, 147-155.
68. Hollenbeak, C. S., Murphy, D. M., Koenig, S., Woodward R. S., Dunagan, W., and Fraser, V J., 2000, The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest, 118, 397-402.
69. Holmberg, S. D., Solomon, S. L., and Blake, P. A., 1987, Health and economic impacts of antimicrobial resistance. Rev. Infect. Dis., 9, 1065-1078.
70. Hori, S., Sunley, R., Tami, A., and Grundmann, H., 2002, The Nottingham Staphylococcus aureus population study: Prevalence of MRSA among the elderly in a university hospital. J. Hosp. Infect., 50, 25-29.
71. Hornberg, C, Schafer, T. R., Koller, A., and Wetz, H. H., 2003, The MRSA patient in technical orthopaedics and rehabilitation, Part 2: Hygiene Management. Orthopade, 32, 218-224.
72. Janknegt, R, 1997, The treatment of staphylococcal infections with special reference to pharmacokinetic, pharmacodynamic and pharmacoeconomic considerations. Pharm. World Sci., 19, 133-141.
73. Jaqua-Stewart, M. J., Tjaden, J., Humphreys, D. W., Bade, P., Tille, P. M., Peterson, K. G et al., 1999, Reduction in methicillin-resistant Staphylococcus aureus infection rate in a nursing home by aggressive containment strategies. S. D. J. Med., 52, 241-247.
74. Jarvis, W. R., 1996, Selected aspects of the socio-economic impact of nosocomial infections: Morbidity, mortality, cost, and prevention. Infect. Control Hosp. Epidemiol., 17, 552-557.
75. Jayaratne, P. and Rutherford, C, 1999, Detection of methicillin-resistant Staphylococcus aureus (MRSA) from growth on mannitol salt oxacillin agar using PCR for nosocomial surveillance. Diagn. Microbiol. Infect. Dis., 35, 13-18.
76. Jernigan, J. A., Clemence, M. A., Stott, G A., Titus, M. G, Alexander, C. H., Palumbo, C. M. et al., 1995, Control of methicillin-resistant Staphylococcus aureus at a university hospital: One decade later. Infect. Control Hosp. Epidemiol., 16, 686-696.
77. Jewell, M., 1994, Cost-containment using an outcome-based best practice model for the management of MRSA. J. Chemother, 6(suppl. 2), 35-39.
78. Jönsson, B. and Lindgren, B., 1980, Five common fallacies in estimating the economic gains of early discharge. Social Sci. Med., 14, 27-33.
79. Karchmer, T. B., Durbin, L. J., Simonto, B. M., and Farr, B. M., 2002, Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J. Hosp. Infect., 51, 126-132.
80. Khan, M. M. and Celik, Y., 2001, Cost of nosocomial infection in Turkey: An estimate based on the university hospital data. Health Serv. Man. Res., 14, 49-54.
81. Khare, M. and Keady, D., 2003, Antimicrobial therapy of methicillin-resistant Staphylococcus aureus infection. Exp. Opin. Pharmacother, 4, 165-177.
82. Kibbler, C. C, Quick, A., and O'Neill, A. M., 1998, The effect of increased bed numbers on MRSA transmission in acute medical wards. J. Hosp. Infect., 39, 213-219.
83. Kim, T, Oh, P. I., and Simor, A. E., 2001, The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect. Control Hosp. Epidemiol, 22, 99-104.
84. Kollef, M. H. and Fraser, V J., 2001, Antibiotic resistance in the intensive care unit. Ann. Intern. Med., 134, 298-314.
85. Korin, J., 1993, Cost implications of malpractice and adverse events. Hosp. Formul., 28(suppl. 1), 59-61.
86. Kunori, T., Cookson, B., Roberts, J. A., Stone, S., and Kibbler, C, 2002, Cost-effectiveness of different MRSA screening methods. J. Hosp. Infect., 51, 189-200.
87. Lacey, R. W., 1987, Multi-resistant Staphylococcus aureus-a suitable case for inactivity? J. Hosp. Infect, 9, 103-105.
88. Landman, D., Chockalingam, M., and Quale, J. M., 1999, Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin. Infect. Dis., 28, 1067-1070.
89. Lankford, M. G., Zembower, T. R., Tricks, W. E., Hacek, D. M., Noskin, G. A., and Peterson, L. R., 2003, Influence of role models and hospital design on hand hygiene of healthcare workers. Emerg. Infect. Dis., 9, 217-223.
90. Larson, E. L., 1995, APIC guideline for handwashing and hand antisepsis in health care settings. Am. J. Infect. Control, 23, 251-269.
91. Law, M. R. and Gill, O. N., 1988, Hospital-acquired infection with methicillin-resistant and methicillin-sensitive staphylococci. Epidemiol. Infect., 101, 623-629.
92. Layton, M. C, Perez, M., Heald, P., and Patterson, J. E., 1993, An outbreak of mupirocinre-sistant Staphylococcus aureus on a dermatology ward associated with an environmental reservoir. Infect. Control Hosp. Epidemiol., 14, 369-375.
93. Linares, L., 2001, The VISA/GISA problem: Therapeutic implications. Clin. Microbiol. Infect., 7(suppl. 4), 8-15.
94. Lucet, J. C, Chevret, S., Durand-Zaleski, I., Chastang, C, and Regnier, B., 2003, Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit results of a multi-centre study. Arch. Intern. Med., 163, 181-188.
95. Lynch, W., Malek, M., Davey, P. G, Byrne, D. J., and Napier, A., 1992, Costing wound infection in a Scottish hospital. Pharmacoeconomics, 2, 163-170.
96. Mahieu, L. M., Buitenweg, N., Bentels, P., and De Dooy, J. J., 2001, Additional hospital stay and charges due to hospital-acquired infections in a neonatal intensive care unit. J. Hosp. Infect., 47, 223-229.
97. Martineau, F., Picard, F. J., Roy, P. H., Ouellette, M., and Bergeron, M. G, 1998, Species-specific and ubiquitous-DNA-based assays for rapid identification of Staphylococcus aureus. J. Clin. Microbiol, 36, 618-623.
98. Mehtar, S., Drabu, Y. J., and Mayet, F., 1989, Expenses incurred during a 5-week epidemic methicillin-resistant Staphylococcus aureus outbreak. J. Hosp. Infect., 13, 199-200.
99. Mehtar, S., 1993, How to cost and fund an infection control programme. J. Hosp. Infect., 25, 57-69.
100. Mehtar, S., 1995, Infection control programmes-are they cost-effective? J. Hosp. Infect., 30(suppl), 26-34.
101. Merrer, J., Santoli, F., Appere de Vecchi, C, Tran, B., De Jonghe, B., and Outin, H., 2000, "Colonisation pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect. Control Hosp. Epidemiol., 21, 718-723.
102. Miller, P. J., Farr, B. M., and Gwaltney, J. M., Jr., 1989, Economic benefits of an effective infection control program: Case study and proposal. Rev. Infect. Dis., 11, 284-288.
103. Monnet, D. L., 1998, Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: Possible implications for control. Infect. Control Hosp. Epidemiol., 19, 552-559.
104. Monnet, D. L. and Frimodt-Moller, N, 2001, Antimicrobial-drug use and methicillin-resistant Staphylococcus aureus. Emerg. Infect. Dis., 7, 161-163.
105. Muder, R. R., Brennen, C, Wagener, M. M., Vickers, R. M., Rihs, J. D., Hancock, G. A. et al., 1991, Methicillin-resistant staphylococcal colonisation and infection in a long-term care facility. Ann. Intern. Med., 114, 107-112.
106. Murray-Leisure, K. A., Geib, S., Graceley, D., Rubin-Slutsky, A. B., Saxena, N, Muller, H. A. et al., 1990, Control of epidemic methicillin-resistant Staphylococcus aureus. Infect. Control Hosp. Epidemiol., 11, 343-350.
107. Muto, C. A., Jernigan, J. A., Ostrowsky, B. E., Richet, H. M., Jarvis, W. R, Boyce, J. M. et al., 2003, SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect. Control Hosp. Epidemiol., 24, 362-386.
108. McLaws, M. L., Gold, J., King, K., Irwig, L. W., and Berry, G, 1988, The prevalence of nosocomial and community-acquired infections in Australian hospitals. Med. J. Aust., 149, 582-590.
109. Nathwani, D., 2001, The management of skin and soft tissues infections: Outpatient parenteral antibiotic therapy in the United Kingdom. Chemotherapy, 47(suppl. 1), 17-23.
110. Nathwani, D., 2003, Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: Does reducing the length of hospital stay matter? J. Antimicrob. Chemother, 51(suppl.S2), ii37-ii44.
111. Nettleman, M. D., Trilla, A., Fredrickson, M., and Pfaller, M., 1991, Assigning responsibility: Using feedback to achieve sustained control of methicillin-resistant Staphylococcus aureus. Am. J. Med., 91, 228S-232S.
112. Niederman, M. S., 2001a, Cost effectiveness in treating ventilator-associated pneumonia. Crit. Care, 5, 243-244.
113. Niederman, M. S., 2001b, Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit. Care Med., 29(suppl. 4), N114-N120.
114. Noel, I., Hollyoak, V, and Galloway, A., 1997, A survey of the incidence and care of postoperative wound infections in the community. J. Hosp. Infect., 36, 267-273.
115. Olson, M. D., 1981, Medicolegal review: Nosocomial infections next target for malpractice suits. Hosp. Med. Staff, 10, 19-24.
116. Olson, M., O'Connor, M., and Schwartz, M. L., 1984, Surgical wound infections. A five-year prospective study of 20, 193 wounds at the Minneapolis VA Medical Centre. Ann. Surg., 199, 253-259.
117. Paladino, J. A., Sunderlin, J. L., Price, C. S., and Schentag, J. J., 2002, Economic consequences of antimicrobial resistance. Surg. Infect. (Larchmt), 3, 259-267.
118. Pan, A., Catenazzi, P., Ferrari, L., Tinelli, C, Seminari, E., Ratti, A. et al., 2001, Evaluation of the efficacy of a program to control nosocomial spread of methicillin-resistant Staphylococcus aureus. Infez. Med., 9, 163-169.
119. Papia, G, Louie, M., Tralla, A., Johnson, C, Collins, V, and Simor, A. E., 1999, Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: Is it cost effective? Infect. Control Hosp. Epidemiol., 20 473-477.
120. Pena, C, Pujol, M., Pallares, R., Corbella, X., Vidal, T, Tortras, N. et al., 1996, Estimation of costs attributable to nosocomial infection: Prolongation of hospitalisation and calculation of alternative costs. Med. Clinica, 106, 441-444.
121. Pfaller, M. A., Jones, R. N., Doern, G V, and Kugler, K, 1998, Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob. Agents Chemother., 42, 1762-1770.
122. Pinner, R. W., Haley, R. W., Blumenstein, B. A., Schaberg, D. R, Von Allmen, S. D., and McGowan, J. E., Jr., 1982, High cost nosocomial infections. Infect. Control, 3, 143-149.
123. Pittet, D., Hugonnet, S., Harbarth, S., Mourouga, P., Sauvan, V, Touveneau, S. et al., and members of the infection control programme, 2000, Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet, 356, 1307-1312.
124. Pittet, D., Tarara, D., and Wenzel, R P., 1994, Nosocomial blood-stream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA, 271, 1598-1601.
125. Plowman, R, Graves, N, Griffin, M. A. S., Roberts, J. A., Swan, A. V, Cookson, B. et al., 2001, The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J. Hosp. Infect., 47, 198-209.
126. Poulsen, K. B., Bremmelgaard, A., Sorensen, A. I., Raahave, D., and Petersen, J. W., 1994, Estimated costs of post-operative wound infections. A case-control study of marginal hospital and social security costs. Epidemiol. Infect., 113, 283-295.
127. Poulsen, K. B. and Gottschau, A., 1997, Long-term prognosis of patients with surgical wound infections. World J. Surg., 21, 799-804.
128. Rampling, A., Wiseman, S., and Davis, L., 2001, Evidence that hospital hygiene is important in the control of methicillin-resistant Staphylococcus aureus. J. Hosp. Infect., 49, 109-116.
129. Rao, N, Jacobs, S., and Joyce, L., 1988, Cost-effective eradication of an outbreak of methicillin-resistant Staphylococcus aureus in a community teaching hospital. Infect. Control Hosp. Epidemiol., 9, 255-260.
130. Reboli, A. C., John, J. F., Jr., and Levkoff A. H, 1989, Epidemic methicillin-gentamicinresis-tant Staphylococcus aureus in a neonatal intensive care unit. Am. J. Dis. Child., 143, 34-39.
131. Reid, R, Simcock, J. W., Chisholm, L., Dobbs, B., and Frizelle, F. A., 2002, Post-discharge clean wound infections: Incidence underestimated and risk factors overemphasised. ANZ J. Surg., 72, 339-343.
132. Reilly, J., Twaddle, S., McIntosh, J., and Kean, L., 2001a, An economic analysis of surgical wound infection. J. Hosp. Infect., 49, 245-249.
133. Reilly, J. S., Baird, D., and Hill, R, 2001b, The importance of definitions and methods in surgical wound infection audit. J. Hosp. Infect., 47, 64-66.
134. Reimer, K., Gleed, C., and Nicolle, L. E., 1987, The impact of post-discharge infection on surgical wound infection rates. Infect. Control, 8, 237-240.
135. Robinson, R., 1993, Economic evaluation and health care: What does it mean? BMJ, 307, 670-673.
136. Romero-Vivas, J., Rubio, M., Fernandez, C., and Picazo, J. J., 1995, Mortality associated with nosocomial bacteraemia due to methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis., 21, 1417-1423.
137. Rose, R., Hunting, K. J., Townsend, T. R, and Wenzel, R. P., 1977, Morbidity/mortality and economics of hospital-acquired bloodstream infections: A controlled study. S. Med. J., 70, 1267-1269.
138. Rubin, R J., Harrington, C. A., Poon, A., Dietrich, K., Greene, J. A., and Moiduddin, A., 1999, The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg. Infect. Dis., 5, 9-17.
139. Rubinovitch, B. and Pittet, D, 2001, Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: What have we learned? J. Hosp. Infect., 47, 9-18.
140. Sanford, M. D, Widmer, A. F., Bale, M. J., Jones, R. N, and Wenzel, R P., 1994, Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis., 19, 1123-1128.
141. Sanyal, S. C. and Mokaddas, E. M., 1999, The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen. J. Chemother., 11, 28-33.
142. Schaberg, D. R., Culver, D. H., and Gaynes, R. P., 1991, Major trends in the microbial aetiology of nosocomial infection. Am. J. Med., 91, 72S-75S.
143. Schentag, J. J., Hyatt, J. M., Carr, J. R, Paladino, J. A., Birmingham, M. C, Zimmer, G. S. et al., 1998, Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control. Clin. Infect. Dis., 26, 1204-1214.
144. Scolan, V, Telmon, N., Rouge, J. C., and Rouge, D., 2000, Medical responsibility and nosocomial infections. Rev. Med. Intern., 21, 361-367.
145. Selkon, J. B., 1980, The role of an isolation unit in the control of hospital infection with methicillin-resistant staphylococci. J. Hosp. Infect., 1, 41-46.
146. Shanson, D., Johnstone, D., and Midgley, J., 1985, Control of a hospital outbreak of methi-cillin resistant Staphylococcus aureus infections: Value of an isolation unit. J. Hosp. Infect., 6, 285-292.
147. Shrestha, N. K., Shermock, K. M., Gordon, S. M., Tuohy, M. J., Wilson, D. A., Cwynar, R E. et al., 2003, Predicitive value and cost-effectiveness analysis of a rapid polymerase chain reaction for preoperative detection of nasal carriage of Staphylococcus aureus. Infect. Control Hosp. Epidemiol., 24, 327-333.
148. Singer, M. E., Harding, I., Jacobs, M. R., and Jaffe, D. H., 2003, Impact of antimicrobial resistance on health outcomes in the outpatient treatment of adult community-acquired pneumonia: A probability model. J. Antimicrob. Chemother, 51, 1269-1282.
149. Smyth, E. T. and Emmerson, A. M., 2000, Surgical site infection surveillance. J. Hosp. Infect., 45, 173-184.
150. Spengler, R F. and Greenough, W. B., 3rd, 1978, Hospital costs and mortality attributed to nosocomial bacteraemias. JAMA, 240, 2455-2458.
151. Spicer, W. J., 1984, Three strategies in the control of staphylococci including methicillin-resistant Staphylococcus aureus. J. Hosp. Infect., 5(suppl. A), 45-49.
152. Stamm, A. M., Long, M. N., and Belcher, B., 1993, Higher overall nosocomial infection rate because of increased attack rate of methicillin-resistant Staphylococcus aureus. Am. J. Infect. Control, 21, 70-74.
153. Stockley, J. M., Allen, R M., Thomlinson, D. F., and Constantine, C. E., 2001, A district general hospital's method of post-operative infection surveillance including post-discharge follow-up, developed over a five-year period. J. Hosp. Infect., 49, 48-54.
154. Talon, D., 1999, The role of the hospital environment in the epidemiology of multi-resistant bacteria. J. Hosp. Infect., 43, 13-17.
155. Talon, D., Vichard P., Muller, A., Bertin, M., Jeunet, L., and Bertrand X., 2003, Modelling the usefulness of a dedicated cohort facility to prevent the dissemination of MRSA. J. Hosp. Infect., 54, 57-62.
156. Tarzi, S., Kennedy, P., Stone, S., and Evans, M., 2001, Methicillin-resistant Staphylococcus aureus: Psychological impact of hospitalisation and isolation in an older adult population. J. Hosp. Infect., 49, 250-254.
157. Teare, E. L. and Barrett, S. P., 1997, Is it time to stop searching for MRSA? Stop the ritual of tracing colonised people. BMJ, 314, 666-667.
158. Teare, L., 2000, Lavate vestras manus. CPD Infect., 2, 51-53.
159. Tokue, Y., Shoji, S., Satoh, K., Watanabe, A., and Motomiya, M., 1992, Comparison of a polymerase chain reaction assay and a conventional microbiologic method for detection of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother, 36, 6-9.
160. Van den Bergh, M. F. Q., Kluytmans, J. A. J. W., van Hout, B. A., Maat, A. P., Seerden, R. J., McDonnel, J. et al., 1996, Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery. Infect. Control Hosp. Epidemiol., 17, 786-792.
161. Venezia, R. A., Domaracki, B. E., Evans, A. M., Preston, K. E., and Graffunder, E. M., 2001, Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure. J. Antimicrob. Chemother, 48, 375-381.
162. Vinken, A., Li, Z., Balan, D., Rittenhouse, B., Welike, R., and Nathwani, D., 2001, Economic evaluation of linezolid, flucloxacillin and vancomycin in the empirical treatment of cellulitis in UK hospitals: A decision analytical model. J. Hosp. Infect., 49(suppl. A), S13-S24.
163. Vriens, M., Blok, H., Fluit, A., Troelstra, A., Van Der Werken, C, and
164. Wakefield D. S., Helms, C. M., Massanari, R. M., Mori, M., and Pfaller, M., 1988, Cost of nosocomial infection: Relative contributions of laboratory, antibiotic and per diem costs in serious Staphylococcus aureus infections. Am. J. Infect. Control, 16, 185-192.
165. Walker, A., 2002, Hospital-acquired infection and bed use in NHS Scotland. Accessed at http://www.ageconcernscotland.org.uk/pdf.pl?file=HAI-Rept. pdf
166. Walsh, T. R. and Howe, R. A., 2002, The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Ann. Rev. Microbiol., 56, 657-675.
167. Webster, J., Faoagali, J. L., and Cartwright, D., 1994, Elimination of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with tri-closan. J. Paediatr. Child Health, 30, 59-64.
168. Wenzel, R. P., 1995, The Lowbury Lecture. The economics of nosocomial infections. J. Hosp. Infect., 31, 79-87.
169. Whitehouse, J. D., Friedman, N. D., Kirkland, K. B., Richardson, W J., and Sexton, D. J., 2002, The impact of surgical-site infections following orthopaedic surgery at a community hospital and a university hospital: Adverse quality of life, excess length of stay, and extra costs. Infect. Control Hosp. Epidemiol., 23, 183-189.
170. Wilson, P. and Dunn, L. J., 1996, Using an MRSA scoring system to decide whether patients should be nursed in isolation. Hyg. Med., 21, 465-477.
171. Witte, W, Kresken, M., Braulke, C, and Cuny, C, 1997, Increasing incidence and widespread dissemination of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals in central Europe, with special reference to German hospitals. Clin. Microbiol. Infect., 3, 414-422.
172. Woodward R S., Medoff, G, Smith, M. D, and Gray, J. L., 3rd, 1987, Antibiotic cost savings from formulary restrictions and physicians monitoring in a medical-school-affiliated hospital. Am. J. Med, 83, 817-823.
173. Zoutman, D., McDonald, S., and Vethanayagan, D., 1998, Total and attributable costs of surgical-wound infections at a Canadian tertiary-care centre. Infect. Control Hosp. Epidemiol., 19, 254-259.